REVIEW 3 major objections 6 minor 5 references
Cargo Delivery to Cells Using Laser-Irradiated Carbon-Black-Loaded PDMS
T0 review · 3 major / 6 minor · reviewed 2026-08-11 · deepseek-v4-flash
Pith's one-line read Laser-heated carbon black in PDMS delivers fluorescent cargo and siRNA into cells with spatial and temporal control, including 45% siRNA delivery into hard-to-transfect K562 suspension cells at near-100% reported viability.
desk verdict Genuinely new CB-PDMS photothermal delivery configuration, but the headline efficiency and near-100% viability claims need quantitative backing before publication. read the letter →
The pith
A machine-rendered reading of the paper's core claim, the machinery that carries it, and where it could break.
The reading
What carries the argument
The central object is carbon-black-embedded polydimethylsiloxane (CB-PDMS): carbon black nanoparticles are mixed into the bulk of PDMS so cells contact only the biocompatible polymer while the embedded particles absorb near-infrared light. Nanosecond laser pulses cause transient photothermal heating and membrane disruption, creating small pores that allow extracellular cargo to diffuse into the cytoplasm and then heal. For suspension cells, soft-lithography microcuvette chambers of defined height (10 to 15 µm) geometrically confine cells against the substrate, increasing photothermal energy transfer; channel height, carbon black concentration, cargo size, and laser fluence all tune delivery. Spatial selectivity comes from raster-scanning the laser beam with a motorized stage, enabling arbitrary patterns of delivery in a single device.
What would settle it
Run flow cytometry on K562 cells immediately after irradiation at 50 mJ/cm$^2$ in 12-µm chambers, adding a membrane-impermeable fluorescence quencher such as trypan blue or an anti-FITC antibody, and simultaneously counting propidium-iodide-positive cells. If most of the fluorescent signal is quenched or colocalizes with dead cells, the cytoplasmic-delivery and near-100%-viability claims would be contradicted; if quenching removes little signal and dead cells are rare, the claims stand.
Extended reading notes
Core claim
The central claim is that carbon-black-embedded PDMS irradiated by 1064-nm, 11-nanosecond laser pulses achieves spatiotemporally selective intracellular delivery without carriers or viral vectors. On flat substrates, the paper demonstrates sequential delivery of two different fluorescent cargoes to different populations of adherent HeLa cells. In microcuvette chambers, it demonstrates delivery of FITC-dextran (4, 10, 20, and 70 kDa) and Cy3-siRNA into K562 suspension cells, with delivery efficiency decreasing as cargo hydrated radius increases and siRNA uptake leveling off around 45.9% at 5 µM and above. Delivery improves when the chamber height is reduced to compress cells against the substrate, and the paper states viability remains near 100% compared with untreated controls, though it reports no quantitative viability data.
Load-bearing premise
The paper's efficiency and safety figures rest on the assumption that the fluorescence readout reports genuine cytoplasmic delivery of intact cargo and that viability is indeed near 100%, even though no quantitative viability data are shown.
Editorial extensions
If this is right
- Sequential delivery: the same substrate can be re-scanned after changing the cargo medium, allowing different molecules to be delivered to the same or different cells in one device, as demonstrated with calcein green and dextran blue on HeLa cells.
- Hard-to-transfect suspension cells: K562 cells took up siRNA with roughly 45% efficiency at concentrations of 5 µM and above, suggesting applicability to blood and immune cells where conventional transfection is difficult.
- Size-dependent delivery: because larger cargo molecules enter less efficiently, the transient pores appear small and size-selective, providing a simple predictor for which biomolecules can be delivered without optimization.
- Low-cost scalable fabrication: CB-PDMS can be cast into Petri dishes or molded into microcuvette chambers using standard soft lithography, so the platform can be integrated into commonplace lab cultureware.
- Spatially patterned populations: laser scanning along arbitrary paths creates distinct cell populations within a single chamber, which could support co-culture studies and combination therapies.
Reading between the lines
- If the transient pores are genuinely size-selective and reseal without killing cells, the platform could plausibly deliver proteins, CRISPR ribonucleoproteins, or nanoparticles up to a size cutoff; testing delivery of a functional, non-fluorescent cargo with a phenotypic readout would distinguish true cytosolic delivery from surface-associated fluorescence.
- The near-100% viability claim is the most fragile link, since the paper explicitly says viability was not reported quantitatively; a routine propidium-iodide flow-cytometry count immediately after irradiation would either confirm the safety margin or narrow the usable fluence window.
- Because 1064-nm light penetrates tissue better than visible light, the approach hints at implantable or insertable CB-PDMS devices for in vivo delivery, but that extension requires substantial validation and is not demonstrated here.
- The sequential-delivery demonstration used adherent cells only; extending the microcuvette design to time-staggered delivery of different cargoes to the same suspension cells would be a direct next step.
Signed reviews
Editorial analysis
A structured set of objections, weighed in public.
Referee Report
Summary. The paper introduces carbon-black-embedded polydimethylsiloxane (CB-PDMS) substrates that, when irradiated with nanosecond laser pulses, generate transient photothermal pores in cell membranes for intracellular delivery of fluorescent cargo. The authors demonstrate sequential delivery of two dyes to adherent HeLa cells with spatial patterning, and delivery of FITC-Dextran and Cy3-siRNA to hard-to-transfect K562 suspension cells in microcuvette chambers. The central claim is that the platform achieves spatiotemporally selective, carrier-free delivery with high efficiency (45.9% for siRNA in K562 cells) and near-perfect viability (~100%).
Significance. If the delivery efficiency and near-100% viability claims are quantitatively supported, this low-cost, scalable optoporation platform would be a useful addition to intracellular delivery methods, particularly for hard-to-transfect suspension cells such as K562. The use of an embedded photothermal absorber avoids nanoparticle exposure to cells, and the spatial/sequential delivery demonstrations are technically appealing. However, the manuscript currently lacks the quantitative flow-cytometry gating, viability data, and controls needed to substantiate these headline numbers, so the significance cannot be fully assessed as written.
major comments (3)
- [§3 (Delivery to Suspension Cells) vs Supplementary Methods] The main text states that at 50 mJ/cm² 'viability is 100% — identical to a control group of cells that are neither injected into the chamber nor irradiated,' and later asserts 'cell viability after siRNA delivery remains nearly 100%.' However, the Supplementary Methods explicitly state that 'Viability is not reported as we observe that it is nearly 100%.' This is an internal contradiction, and no quantitative viability measurements (e.g., PI/DAPI percentages, gating) are provided in either the main text or the SI. The near-100% viability claim is therefore unsupported as stated and should be reconciled and backed by data.
- [Figure 3 and flow-cytometry methods] The delivery efficiencies—including the headline 45.9% for Cy3-siRNA—are reported as single percentages with no shown flow-cytometry gates, no control positivity values, and no visible error bars, despite the text stating that 'standard error is denoted.' Without the gating strategy (e.g., whether the viable-cell gate or the full irradiated population is the denominator, and how the Cy3-positive boundary is set relative to no-laser controls), the delivery percentages and the molecular-weight and concentration trends in Figure 3 cannot be verified or reproduced from the manuscript.
- [Methods, 'FITC-dextran and Cy3-siRNA delivery to K562 cells'] Flow cytometry of washed cells cannot by itself distinguish genuine cytoplasmic delivery from cargo attached to the outer membrane or trapped in endosomes. The confocal images are qualitative and no z-stacks, side-scatter gating for membrane-bound dye, or membrane-impermeant quenching controls are provided. Because the paper's core claim is intracellular delivery, this missing control is load-bearing; additional evidence is needed to confirm that the measured fluorescence corresponds to cytosolic cargo.
minor comments (6)
- [Abstract and §3] The phrase 'nearly 100% cell viability' in the abstract should be qualified consistently with the level of evidence actually presented; as written it implies a quantitative measurement that is not reported.
- [Figure 3 caption] The caption states 'standard error is denoted' but no error bars appear in the figure; please either add the bars or remove the statement.
- [Page 5, Delivery to Adherent Cells] The sentence 'After five minutes, we replace the dextran blue solution with a 0.57-mg/mL solution of calcein green' is repeated nearly verbatim later in the text; this duplication should be cleaned up.
- [Page 6, channel-height discussion] The claim that 'increased contact with the substrate significantly improves the efficiency' is presented with a 30% increase when reducing channel height from 15 to 12 µm, but no numerical delivery percentages or error bars are given for these values; please report the underlying data.
- [Page 19 (method), 'Viability is not reported'] The statement 'To check the viability either propidium iodide (FITC-Dextran delivery) or DAPI stain (siRNA delivery)' is followed by 'Viability is not reported as we observe that it is nearly 100%.' This is confusingly worded: if viability was checked with these stains, the results should be reported; if not, the sentence should be reworded to avoid implying a measurement was made.
- [References] References 31 and 35 are identical; consider consolidating them.
Circularity Check
No circularity: the paper is an experimental demonstration with no derivation chain; delivery efficiencies and viability are measured outputs, not fitted inputs or self-cited constructs.
full rationale
This manuscript reports an experimental platform and does not present a derivation chain that could reduce to its own inputs. The central quantitative claims, such as 45% Cy3-siRNA delivery efficiency and near-100% viability, are presented as flow-cytometry and confocal measurements rather than as outputs of a model fitted to data. The parametric studies (carbon-black loading, channel height, fluence, cargo molecular weight, siRNA concentration) are empirical optimizations reported honestly: the chosen 2 wt% CBNP concentration and 50 mJ/cm2 fluence are selected from measured delivery and recovery behavior, not derived from a self-defined quantity. There is no fitted parameter later renamed as a prediction, no uniqueness theorem imported from the authors' prior work, and no ansatz smuggled in via self-citation; the cited references support standard materials and methods (PDMS, soft lithography, photoporation) and are not load-bearing for the paper's own claims. The apparent tension between the main-text statement that viability is 100% and the Supplementary statement that viability is not reported is an internal consistency and evidence-quality problem, not a circular one, because neither statement is used to define or fit the other. No circular step can be exhibited from the text, so the appropriate circularity score is 0.
Assumptions & free parameters
free parameters (4)
- CBNP loading =
2 wt% (microcuvettes), 5 wt% (flat substrates)
- Laser fluence =
50 mJ/cm²
- Channel height =
12 µm (10 µm for some experiments)
- Laser pulses per cell =
8 pulses
assumptions (4)
- domain assumption Fluorescence signal indicates intracellular cargo delivery.
- domain assumption Cell viability is near 100% as stated.
- domain assumption Photothermal membrane disruption is the operative delivery mechanism.
- domain assumption Carbon black particles remain embedded and do not contact cells.
Cite this review
Pith. "Pith review of Cargo Delivery to Cells Using Laser-Irradiated Carbon-Black-Loaded PDMS." pith.science (2026). https://pith.science/paper/FLNE6OZU
@misc{pith2026241202032,
author = {Pith},
title = {Pith review of: Cargo Delivery to Cells Using Laser-Irradiated Carbon-Black-Loaded PDMS},
year = {2026},
howpublished = {\url{https://pith.science/paper/FLNE6OZU}},
note = {Machine review of arXiv:2412.02032}
}
read the original abstract
Effective intracellular delivery is essential for successful gene editing of cells. Spatially selective delivery to cells that is simultaneously precise, consistent, and non-destructive remains challenging using conventional state-of-the-art techniques. Here, we introduce a carrier-free method for spatiotemporal delivery of fluorescently labeled cargo into both adherent and suspension cells using carbon-black-embedded polydimethylsiloxane (PDMS) substrates irradiated by nanosecond laser pulses. This low-cost, biocompatible material, coupled with an optical approach, enables scalable, spatially selective, and sequential delivery of multiple cargo molecules, including FITC-dextran and siRNA, to a broad range of cells. Notably, we achieved siRNA delivery into the cytoplasm of hard-to-transfect K562 cells with 45% efficiency, while maintaining nearly 100% cell viability.
Reference graph
Works this paper leans on
-
[1]
or microcuvette chambers using standard photolithography techniques (Figure 2a).32 Surface characterization using x-ray photoelectron spectroscopy (XPS) and scanning electron microscopy (SEM) confirms that the CBNPs are embedded consistently within the bulk of the PDMS and are not present on the surface of the substrate (Figure S1). Furthermore, we demons...
work page 2013
-
[53]
https://doi.org/10.1038/s41392-021-00487-6. (12) Al-Dosari, M. S.; Gao, X. Nonviral Gene Delivery: Principle, Limitations, and Recent Progress. AAPS J. 2009, 11 (4),
-
[101]
https://doi.org/10.1038/s41392-020-0207-x. (27) Devi, G. R. siRNA-Based Approaches in Cancer Therapy. Cancer Gene Ther. 2006, 13 (9), 819–829. https://doi.org/10.1038/sj.cgt.7700931. (28) Wolf, M. P.; Salieb-Beugelaar, G. B.; Hunziker, P. PDMS with Designer Functionalities—Properties, Modifications Strategies, and Applications. Prog. Polym. Sci. 2018, 83,...
-
[671]
(13) Ganta, S.; Devalapally, H.; Shahiwala, A.; Amiji, M
https://doi.org/10.1208/s12248-009-9143-y. (13) Ganta, S.; Devalapally, H.; Shahiwala, A.; Amiji, M. A Review of Stimuli-Responsive Nanocarriers for Drug and Gene Delivery. J. Controlled Release 2008, 126 (3), 187–204. https://doi.org/10.1016/j.jconrel.2007.12.017. (14) Mora-Huertas, C. E.; Fessi, H.; Elaissari, A. Polymer-Based Nanocapsules for Drug Deli...
-
[5376]
(31) Kumar, S.; Li, A.; Thadhani, N
https://doi.org/10.3390/molecules26175376. (31) Kumar, S.; Li, A.; Thadhani, N. N.; Prausnitz, M. R. Optimization of Intracellular Macromolecule Delivery by Nanoparticle-Mediated Photoporation. Nanomedicine Nanotechnol. Biol. Med. 2021, 37, 102431. https://doi.org/10.1016/j.nano.2021.102431. (32) Qin, D.; Xia, Y.; Whitesides, G. M. Soft Lithography for Mi...
Reviewed August 11, 2026 · model on record in the stance chip above.
Discussion (0). Continue with ORCID to comment.